Startups
CrannMed was founded in 2018 with the aim of bringing together world-leading clinical, material science and delivery system experts to deliver the benefits of resorbable embolisation to patients worldwide.
Permanent microspheres have existed for more than 20 years, and are routinely used to treat liver cancer, uterine fibroids and benign prostate hyperplasia. Resorbable microspheres can be used to treat a range of new indications where it is desirable to restore blood flow to the targeted area after the desired therapeutic effect has been achieved.
These resorbable microspheres have new applications in areas such as Knee Osteoarthritis (KOA) and Adhesive Capsulitis (Frozen Shoulder) and have the potential to replace permanent beads in existing applications. As well as a range of resorbable microspheres, CrannMed is developing a next generation microcatheter to help improve access for these unique applications plus a flow directed delivery system to protect collateral vessels and eliminate non-target embolisation.
Permanent microspheres have existed for more than 20 years, and are routinely used to treat liver cancer, uterine fibroids and benign prostate hyperplasia. Resorbable microspheres can be used to treat a range of new indications where it is desirable to restore blood flow to the targeted area after the desired therapeutic effect has been achieved.
These resorbable microspheres have new applications in areas such as Knee Osteoarthritis (KOA) and Adhesive Capsulitis (Frozen Shoulder) and have the potential to replace permanent beads in existing applications. As well as a range of resorbable microspheres, CrannMed is developing a next generation microcatheter to help improve access for these unique applications plus a flow directed delivery system to protect collateral vessels and eliminate non-target embolisation.
Overview
Location
Ireland
Employees
11-50
Total raised
$14.62M
Founded date
2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 15, 2020 | EIT Health names winning longevity innovations | EIT Health, together with seven global collaborators representing nearly 50 countries and territories, today announced the winners of the inaugural round of Healthy Longevity Catalyst Awards. The awards are part of the Healthy Longevity Glo... |
Reviews 0
FAQ about CrannMed
When was CrannMed founded?
CrannMed was founded in 2018.
How much funding has CrannMed raised?
CrannMed has raised $14.62M in total across 1 funding round.
What has the press written about CrannMed?
Parsers VC has collected 2 articles mentioning CrannMed, among them “EIT Health names winning longevity innovations” (Oct 15, 2020).
Is CrannMed still active?
Yes, CrannMed is active; its latest activity on Parsers VC dates from Feb 26, 2026.